Insights

Strategic position EVERSANA operates as an integrated commercialization platform spanning pricing, market access, patient support, and channel distribution, indicating a holistic solution for pharma clients from start-ups to established companies. This presents cross-sell opportunities across RWE, HEOR, and AI-powered marketing and analytics services.

AI driven growth Recent expansions of the AI powered commercialization platform and partnerships to deploy AI solutions for strategy, content creation, omnichannel engagement, and analytics suggest strong opportunities to upsell advanced analytics, MLR automation, and AI-enabled medical information services to current and prospective clients.

Real world evidence Strategic collaboration with Pulse Infoframe to combine real-world evidence with commercialization and market access indicates a growing demand for RWE capabilities in evidence generation, health economics, and payer-focused insights to support product launches and lifecycle management.

Industry expansion Active hiring and notable leadership movements in market access roles signal ongoing capability building and potential for new logos in complex markets. This suggests targeting manufacturers seeking expertise in navigating pricing, access, and payer negotiations.

Clinical and biotech focus Recent exclusive U.S. commercialization deals, including with Innovacell for regenerative medicine and cell therapies, highlight a momentum in enabling novel modalities. This opens up opportunities to engage biotech and specialty pharma clients needing specialized go-to-market and launch support.

Similar companies to Dohmen Life Science Services

Dohmen Life Science Services Tech Stack

Dohmen Life Science Services uses 8 technology products and services including Facebook Ads, iCIMS, Databricks, and more. Explore Dohmen Life Science Services's tech stack below.

Media & News

Dohmen Life Science Services's Email Address Formats

Dohmen Life Science Services uses at least 5 email formats:
Dohmen Life Science Services Email FormatsExamplePercentage
First.Last@dlss.comJohn.Doe@dlss.com
97%
First.L@dlss.comJohn.D@dlss.com
3%
First.Last@eversana.comJohn.Doe@eversana.com
97%
FLast@eversana.comJDoe@eversana.com
2%
First.Middle@eversana.comJohn.Michael@eversana.com
1%

Frequently Asked Questions

What is Dohmen Life Science Services's official website and social media links?

Minus sign iconPlus sign icon
Dohmen Life Science Services's official website is eversana.com and has social profiles on LinkedIn.

How much revenue does Dohmen Life Science Services generate?

Minus sign iconPlus sign icon
As of October 2026, Dohmen Life Science Services's annual revenue is estimated to be $100M - $250M.

What is Dohmen Life Science Services's NAICS code?

Minus sign iconPlus sign icon
Dohmen Life Science Services's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Dohmen Life Science Services have currently?

Minus sign iconPlus sign icon
As of October 2026, Dohmen Life Science Services has approximately 103 employees across 4 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: P. A., Chief Commercial Officer: C. Q. and Vice President Corporate Communications: C. P. Explore Dohmen Life Science Services's employee directory with LeadIQ.

What industry does Dohmen Life Science Services belong to?

Minus sign iconPlus sign icon
Dohmen Life Science Services operates in the Pharmaceutical Manufacturing industry.

What technology does Dohmen Life Science Services use?

Minus sign iconPlus sign icon
Dohmen Life Science Services's tech stack includes Facebook Ads, iCIMS, Databricks, SAP, Microsoft SQL Server, Simpli.fi, Vertex AI and VMware.

What is Dohmen Life Science Services's email format?

Minus sign iconPlus sign icon
Dohmen Life Science Services's email format typically follows the pattern of First.Last@dlss.com. Find more Dohmen Life Science Services email formats with LeadIQ.

When was Dohmen Life Science Services founded?

Minus sign iconPlus sign icon
Dohmen Life Science Services was founded in 2018.
Dohmen Life Science Services logo

Dohmen Life Science Services

Pharmaceutical ManufacturingWisconsin, United States51-200 Employees

Dohmen Life Science Services is now EVERSANA, a provider within an integrated, global platform for life science commercialization. The company offers services that span patient experience, global pricing and market access, marketing, patient support, channel distribution, and consulting to help medicines progress through the product lifecycle. It serves a range of clients from innovative start-ups to established pharmaceutical companies, aiming to create value for patients, prescribers, and payers across different markets. The description reflects an objective view of a service-oriented organization operating in the life sciences space.

Headquartered in Milwaukee, Wisconsin, EVERSANA operates within the pharmaceutical manufacturing and life sciences services sector as a mid-sized provider. A recent development cited in 2026 involves a commercialization agreement with Candel Therapeutics to support the potential U.S. launch of aglatimagene besadenovec for localized prostate cancer.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $100M - $250M

    Dohmen Life Science Services's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.